"Designing Growth Strategies is in our DNA"
In March 2018, Sebia, one of the prominent players in multiple myeloma monitoring and diagnostics market, announced the launch of its new generation serum free light chain assays, Sebia FLC Lambda and FLC Kappa. The newly launched assays are incorporated with an advanced Enzym Linked Immunosorband Assay technology, enabling simpler diagnosis and monitoring of multiple myeloma for healthcare professionals. Serum Free Light Chain Assays is a laboratory-based procedure used to identify an individual’s blood group. Immunoglobulin light chains circulating serum in an unbound state are called free light chains (FLCs). Each immunoglobulin light-chain molecule encompasses of approximately 220 amino acids in a single polypeptide chain which is folded to form constant and variable region domains. The serum free light chain assays are widely used in diagnosis of multiple myeloma and different plasma cell disorders. Diagnosis and monitoring of multiple myeloma (MM) are related conditions and commonly performed by urine and serum protein electrophoresis and immunofixation testing methods.
Key Market Driver -
Increasing incidence and prevalence of the multiple myeloma
Key Market Restraint -
Stringent government regulations
The factors expected to drive the serum free light chain assays (sFLC) market are increasing incidence and prevalence of the multiple myeloma. Multiple myeloma (MM) is a hematological malignancy, with an estimated incidence of 4.4 per 100,000 people per year globally. For instance, according to the World Health Organisation, multiple myeloma (MM) accounts for 0.8% of all cancer deaths globally. Moreover, higher efficiency of the test for diagnosis of multiple myeloma is projected to drive the global serum free light chain assays market during the forecast period.
However, stringent government regulations in developed, as well as developing countries, are anticipated to hamper the growth of the global serum free light chain assays market by 2026.
By sample type, the market is segmented into serum, plasma, and urine. Based on the end user, the global serum free light chain assays (sFLCs) can be segmented into hospitals, clinical & pathology laboratories, and others.
From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The major companies in the global serum free light chain assays (sFLC) market report include Biomedical diagnostics, SEBIA, Abingdon Health, Dr Lal PathLabs., he Binding Site Group Ltd., EW SCIENTIFIC COMPANY SRL, Calgary Laboratory Services, QML Pathology, and other prominent players.
To gain extensive insights into the market, Request for Customization
The global serum free light chain assays market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe dominated the global serum free light chain assays market in 2018. Certain factors such as developed healthcare infrastructure, emphasis on research & development, and higher consciousness about serum free light chains assays are attributable to the faster growth of the market in these regions. In Asia Pacific, boosting healthcare infrastructure in countries such as India & China and rising need for simpler multiple myeloma diagnostic solutions are projected to bolster the growth of the Asia Pacific serum free light chain assays market during the forecast period. Unmet demand in Latin America and Middle East & Africa are anticipated to offer a lucrative opportunity for the market in these regions.
By Sample Type
By End User
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry